Showing results (31-40 of 631) with videos related to
Sort By:
Pageof 64
Gastroenterology Clinics of North America|September 6, 2006
Surveillance for cancer and dysplasia in inflammatory bowel diseaseDavid T Rubin, Robert T KavittJournal of Crohn'S & Colitis|September 17, 2014
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysisRuben J Colman, David T RubinTherapeutic Advances in Gastroenterology|July 2, 2016
Current approaches for optimizing the benefit of biologic therapy in ulcerative colitisM Anthony Sofia, David T RubinJournal of Crohn'S & Colitis|January 25, 2015
Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel diseaseRuben J Colman, David T RubinGastrointestinal Endoscopy Clinics of North America|November 7, 2024
Endoscopy in Inflammatory Bowel Disease: Indications, Timing, and Biopsy ProtocolJoëlle St-Pierre, David T RubinThe American Journal of Gastroenterology|June 3, 2005
Will a 5-ASA a day keep the cancer (and dysplasia) away?David T Rubin, Bret A LashnerThe Medical Clinics of North America|December 1, 2009
Novel diagnostic and prognostic modalities in inflammatory bowel diseaseTimothy L Zisman, David T RubinGastroenterology Clinics of North America|November 17, 2009
Novel diagnostic and prognostic modalities in inflammatory bowel diseaseTimothy L Zisman, David T RubinThe American Journal of Gastroenterology|April 8, 2015
Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel DiseaseDavid T Rubin, Noa Krugliak ClevelandGastrointestinal Endoscopy Clinics of North America|July 1, 2014
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel diseaseChristopher G Chapman, David T RubinPageof 64